In September 2012, experts from the National Institutes of Health (NIH), Department of Defense (DoD), U.S. Food and Drug Administration (FDA), Department of Veterans Affairs (VA), academia, and industry attended a workshop to discuss new findings on the risks and benefits of FDA-approved HES, which is used to treat low blood volume.
Research Meeting Summaries
Filter Research Meeting Summaries
In June 2012, a working group recommended actions to advance the development and application of point-of-care (POC) technologies as tools for diagnosis and monitoring in clinical cardiovascular research.
In June 2012, a working group explored the issues relevant to thrombosis (prevention, detection/surveillance, and treatment) in pediatric cardiology and adult congenital heart disease patients and made recommendations to improve the knowledge base in this field.
In June 2012, a working group identified knowledge gaps regarding exercise training as a treatment for heart failure and suggested approaches to filling those gaps.
In June 2012, a working group discussed current knowledge and future directions for research in prediction, prevention, and treatment of pulseless electrical activity (PEA), which is a clinical condition characterized by unresponsiveness and lack of a pulse despite organized cardiac electrical activity.
In June 2012, a working group discussed gaps in knowledge of best clinical practices for surgical and endovascular treatment of peripheral vascular disease (PVD) and sought consensus on PVD research priorities.
This report summarizes a December 2011 workshop at which experts recommended steps to advance research on the role of the lung microbiome in asthma, COPD, and cystic fibrosis.
This report summarizes a September 2011 workshop at which experts discussed the opportunities for and obstacles to the development of cellular therapies for pediatric patients.
This report summarizes a September 2011 workshop at which experts identified key knowledge gaps and priority areas in lung development research.
This report summarizes a September 2011 State of the Science Symposium on the Myelodysplastic Syndromes (MDS), which are a group of bone marrow stem cell disorders involving ineffective blood cell formation.